2002
DOI: 10.1006/clim.2002.5231
|View full text |Cite
|
Sign up to set email alerts
|

Effective Antiretroviral Therapy Reduces Degradation of Tryptophan in Patients with HIV-1 Infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
76
0

Year Published

2006
2006
2020
2020

Publication Types

Select...
6
3

Relationship

3
6

Authors

Journals

citations
Cited by 88 publications
(84 citation statements)
references
References 27 publications
8
76
0
Order By: Relevance
“…The rate of IDO-mediated Trp catabolism is increased during HIV disease progression (16,49). We observed higher IDO expression in the mesenteric LN, jejuna, colons, and spleens of SIV HI animals compared to the same compartments of SIV LO animals.…”
Section: It Is Believed That An Early Loss Of Cd4mentioning
confidence: 58%
“…The rate of IDO-mediated Trp catabolism is increased during HIV disease progression (16,49). We observed higher IDO expression in the mesenteric LN, jejuna, colons, and spleens of SIV HI animals compared to the same compartments of SIV LO animals.…”
Section: It Is Believed That An Early Loss Of Cd4mentioning
confidence: 58%
“…The variations of plasma Neo levels also support a rebound in type 1 Th cell responses associated with IFN-␥ production (16). It is well described that Neo production in humans correlates with T cell activation (37,38), and the observed changes in Neo and Kyn/ Trp may both reflect swings in immune activation. Thus, although we cannot exclude that D-1mT administration affected Trp plasma levels by mechanisms not directly related to IDO inhibition, the changes in Neo, IDO, and IFN-␥, as well as the observed increase in plasma Kyn, suggest that D-1mT may have favored the activation of compensating immunosuppressive mechanisms, probably triggered by T cell-derived cytokines.…”
Section: Discussionmentioning
confidence: 88%
“…In addition to improving the life expectancy of treated patients by controlling HIV-1 replication, ART inhibits the immunosuppressive tryptophan catabolism (22,34,45,46). To test whether ART could restore the ability of memory CD4 T cells from PHI subjects to respond to IL-2, we collected plasma and PBMCs from HIV-1-infected subjects before treatment (pre-ART) and after 1 year of effective treatment (on ART).…”
Section: Ros Inhibits Il-2 Signaling In Memory Cd4 T Cells During Hivmentioning
confidence: 99%
“…Despite relatively low HIV-1-specific CD8 T-cell responses, recent observations demonstrate a beneficial effect of early initiation of ART in preserving mucosal CD4 T cells, possibly limiting the release of microbial products associated with immune activation (68)(69)(70). It is important to note that the complete reestablishment of IDO-1 activity occurs only when ART is initiated early, in contrast to the partial normalization that occurs when ART is initiated during the chronic phase of infection (34,45,46). Accordingly, we also found a drastic suppression of the Kyn-dependent inhibition of the IL-2 response in memory CD4 T cells after 1 year of ART when ART was initiated during the first months of HIV-1 infection (initiation at 124.6 Ϯ 106.4 days postinfection) (Fig.…”
Section: Ccr7mentioning
confidence: 99%